Delta Pharmaceuticals has 398 million shares outstanding with a current market price of $29 per share. Its stock changed to $32 on the news that Delta Pharmaceuticals’ long-awaited new drug Zentac is to hit the market next month. What’s the market’s consensus of the NPV (in millions) that the new drug will generate for Delta Pharmaceuticals?